SREBF2 and colon adenocarcinoma: Except for SREBP-2 and SCD-1, most of the downstream genes were significantly down-regulated, demonstrating that blockade of cholesterol biosynthesis pathway can inhibit oncogene expression, which may be employed for anti-proliferation and COAD therapy.